의료기기 아웃소싱 시장 보고서 : 서비스, 치료, 용도, 지역별(2025-2033년)

The global medical device outsourcing market size reached USD 136.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 275.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033. The rising need to reduce overall medical costs, the implementation of stringent regulatory requirements and quality standards, the expanding adoption of wearable medical devices, and the surging demand for personalized medicine are among the key factors driving the market growth.

Medical device outsourcing refers to the practice of contracting or partnering with external companies or service providers to handle various aspects of the medical device product lifecycle. These external partners are typically specialized contract manufacturers, design and development firms, regulatory consultants, logistics providers, or other service providers with expertise in the medical device industry. These services offer several benefits to companies, including cost savings, access to specialized expertise, increased operational efficiency, and the ability to adapt to market demands more effectively. It also allows medical device manufacturers to concentrate on core competencies, such as research and development, marketing, and strategic planning, while leveraging the capabilities of external partners to handle other essential aspects of the product lifecycle.

The market is experiencing significant growth due to the increasing prevalence of medical ailments and the surging need for quality healthcare services. In addition, outsourcing offers medical device companies the flexibility to scale production volumes based on market demand. This adaptability is essential for managing fluctuations in product demand, especially for devices with seasonal variations or in response to unexpected market shifts. Moreover, the surging demand for personalized medicine, the expanding adoption of wearable medical devices, the growing popularity of minimally invasive surgical procedures, and the rising trend of home healthcare, telemedicine, and medical tourism are some of the other factors propelling the market. Besides, contract manufacturers with international operations can provide access to diverse markets and navigate import/export regulations, facilitating a smoother expansion into new regions and influencing the market growth.

Medical Device Outsourcing Market Trends/Drivers:

The rising need to reduce overall medical costs

Medical device outsourcing offers cost savings to healthcare providers and medical device companies. Contracting with specialized manufacturers or service providers is more cost-efficient than maintaining in-house operations. External partners have established production facilities, economies of scale, and streamlined processes, enabling them to produce medical devices at lower costs. Moreover, outsourcing non-core activities, such as manufacturing and logistics, allows medical device companies to optimize resource allocation. By delegating routine tasks to external partners, companies can focus their internal resources on core competencies like research, development, and innovation, which can lead to more cost-effective and competitive products.

The implementation of stringent regulatory requirements and quality standards

The implementation of stringent regulations places a higher compliance burden on both medical device companies and their outsourcing partners. Contract manufacturers must adhere to the same regulatory standards as the OEMs to ensure that the medical devices they produce meet the required safety and quality benchmarks. This requires rigorous documentation, quality management systems, and adherence to good manufacturing practices (GMP). Moreover, with higher regulatory scrutiny, quality assurance becomes paramount in the medical device outsourcing process. Contract manufacturers are now under pressure to implement robust quality control measures and risk management strategies to identify and mitigate potential issues in the production process.

The expanding adoption of wearable medical devices

Wearable medical devices often incorporate advanced sensors, wireless connectivity, and sophisticated data analytics capabilities. The development and manufacturing of such technology-intensive devices require specialized expertise and resources, leading to an increased demand for outsourcing partners with expertise in advanced electronics and software development. Moreover, medical devices need to be lightweight, comfortable, and ergonomically designed to ensure user compliance and long-term wearability. Contract manufacturers with expertise in miniaturization techniques and materials selection play a crucial role in achieving these design requirements.

Medical Device Outsourcing Industry Segmentation:

Breakup by Service:

• Regulatory Consulting
• Product Design and Development
• Product Testing and Sterilization
• Product Implementation
• Product Upgrade
• Product Maintenance

Product design and development represent the leading segment

Medical device design and development requires a high level of technical expertise, including knowledge of regulatory requirements, engineering principles, and medical standards. Many medical device companies lack in-house capabilities or resources to handle the complex design process efficiently. Outsourcing product design and development allows them to tap into the specialized expertise of experienced design firms and engineering companies with a proven track record in the medical device industry. Moreover, outsourcing product design and development enables medical device companies to access fresh ideas, creative solutions, and cutting-edge technologies from external design partners.

Breakup by Therapeutics:

• Cardiology
• Diagnostic Imaging
• Orthopedic
• IVD
• Ophthalmic
• General and Plastic Surgery
• Drug Delivery
• Dental
• Endoscopy
• Diabetes Care

Cardiology exhibits a clear dominance in the market

Cardiovascular diseases (CVDs) remain one of the leading causes of death worldwide. The increasing prevalence of conditions such as coronary artery disease, heart failure, and arrhythmias has led to a rising demand for innovative medical devices and technologies to diagnose, treat, and manage these conditions. This high demand has driven medical device companies to focus extensively on cardiology-related products and services, leading to a dominant presence in the outsourcing market. Besides, the field of cardiology has witnessed rapid technological advancements and continuous innovation. These innovations include implantable devices such as pacemakers, defibrillators, stents, and heart valves, as well as diagnostic devices like electrocardiograms (ECGs) and cardiac imaging equipment. To keep up with the pace of innovation and meet market demands, medical device companies often seek specialized outsourcing partners with expertise in cardiology product development.

Breakup by Application:

• Class I
• Class II
• Class III

Class II accounts for the majority of the market share

Class II medical devices encompass a wide range of products, including moderate to high-risk devices that do not fall into the highest-risk Class III category. This broad product range includes items such as infusion pumps, diagnostic imaging equipment, electrocardiographs, surgical instruments, and certain implantable devices. The diversity of Class II devices contributes to a larger market share in the outsourcing industry. Moreover, these medical devices are subject to intermediate levels of regulatory scrutiny compared to Class III devices. While Class II devices must still meet strict regulatory requirements for safety and efficacy, the regulatory process is generally less burdensome and time-consuming than that for Class III devices, which is escalating their demand.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Asia Pacific exhibits a clear dominance, accounting for the largest medical device outsourcing market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Latin America (Mexico, Brazil, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); and Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others). According to the report, Asia Pacific was the largest market for medical device outsourcing.

Asia Pacific countries, such as China, India, and Southeast Asian nations, offer a significant cost advantage in terms of labor and manufacturing. The lower labor costs, combined with well-developed manufacturing infrastructure and supply chain networks, make the region an attractive option for medical device companies seeking cost-effective outsourcing solutions. Moreover, the region boasts a large pool of skilled and trained professionals in engineering, science, and technology fields. This skilled workforce includes engineers, scientists, and technicians with expertise in medical device design, development, and manufacturing. The availability of such talent accelerates the outsourcing process and ensures high-quality products.

Competitive Landscape:

The competitive landscape of the medical device outsourcing market is highly dynamic with numerous companies offering a wide range of outsourcing services to medical device manufacturers. Nowadays, key players are expanding their service portfolios to provide a comprehensive range of outsourcing solutions. They are diversifying their offerings to include contract manufacturing, product design and development, regulatory support, post-market services, packaging, and logistics. Companies are also engaging in mergers, acquisitions, and strategic partnerships to expand their geographical presence and technical capabilities. They are also investing heavily in advanced manufacturing technologies such as automation, robotics, 3D printing, and data analytics to improve production efficiency, reduce costs, and offer faster turnaround times to medical device manufacturers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Celestica Inc. (Onex Corporation)
• Charles River Laboratories International Inc.
• Flex Ltd.
• Freyr Inc.
• Heraeus Holding GmbH
• ICON plc
• Integer Holdings Corporation
• IQVIA Inc.
• Plexus Corp.
• Sanmina Corporation
• TE Connectivity
• West Pharmaceutical Services Inc.

Key Questions Answered in This Report

• 1.What was the size of the global medical device outsourcing market in 2024?
• 2.What is the expected growth rate of the global medical device outsourcing market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global medical device outsourcing market?
• 4.What are the key factors driving the global medical device outsourcing market?
• 5.What is the breakup of the global medical device outsourcing market based on the service?
• 6.What is the breakup of the global medical device outsourcing market based on the therapeutics?
• 7.What is the breakup of the global medical device outsourcing market based on the application?
• 8.What are the key regions in the global medical device outsourcing market?
• 9.Who are the key players/companies in the global medical device outsourcing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Device Outsourcing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Service

• 6.1 Regulatory Consulting
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Product Design and Development
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Product Testing and Sterilization
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Product Implementation
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Product Upgrade
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Product Maintenance
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Therapeutics

• 7.1 Cardiology
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnostic Imaging
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Orthopedic
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 IVD
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Ophthalmic
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 General and Plastic Surgery
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Drug Delivery
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast
• 7.8 Dental
  • 7.8.1 Market Trends
  • 7.8.2 Market Forecast
• 7.9 Endoscopy
  • 7.9.1 Market Trends
  • 7.9.2 Market Forecast
• 7.10 Diabetes Care
  • 7.10.1 Market Trends
  • 7.10.2 Market Forecast

8 Market Breakup by Application

• 8.1 Class I
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Class II
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Class III
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Celestica Inc. (Onex Corporation)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Charles River Laboratories International Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Flex Ltd.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Freyr Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Heraeus Holding GmbH
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 SWOT Analysis
  • 14.3.6 ICON plc
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Integer Holdings Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
  • 14.3.8 IQVIA Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Plexus Corp.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Sanmina Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 TE Connectivity
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 West Pharmaceutical Services Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis